ROLE OF RADIOPROTECTORS IN MINIMIZATION OF STOCHASTIC EFFECTS OF RADIATION INCIDENTS.

Q3 Medicine
E A Domina, O L Kopylenko
{"title":"ROLE OF RADIOPROTECTORS IN MINIMIZATION OF STOCHASTIC EFFECTS OF RADIATION INCIDENTS.","authors":"E A Domina,&nbsp;O L Kopylenko","doi":"10.32471/exp-oncology.2312-8852.vol-44-no-3.18530","DOIUrl":null,"url":null,"abstract":"<p><p>The real threat of emergency situations in Ukraine dictates the need to take into account the experience of previous radiation accidents, during which a significant part of the population was exposed to low-dose radiation. In such a case clinical manifestations of irradiation were mostly absent, while the danger of stochastic (carcinogenic) effects remained. Therefore, at present, the strategy of radiation protection of the population should be aimed at revising and choosing effective and low-toxic anti-radiation means. The main criterion for the development of stochastic consequences of exposure is radiation-induced genome instability, which is a promoter of carcinogenesis. The use of radiomitigators, which are able to weaken the harmful effect of ionizing radiation on critical highly radiosensitive systems of the human body, is promising. Our research showed the radiomitigative effect of inosine in cultured human T-lymphocytes on the genetic level with the significant decrease in the frequency of gamma-induced chromosome aberrations. The results experimentally justified an expediency of use of radiomitigators in the conditions of an emergency situation to minimize the occurrence and development of stochastic effects in population.</p>","PeriodicalId":12287,"journal":{"name":"Experimental oncology","volume":"44 3","pages":"186-189"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18530","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

The real threat of emergency situations in Ukraine dictates the need to take into account the experience of previous radiation accidents, during which a significant part of the population was exposed to low-dose radiation. In such a case clinical manifestations of irradiation were mostly absent, while the danger of stochastic (carcinogenic) effects remained. Therefore, at present, the strategy of radiation protection of the population should be aimed at revising and choosing effective and low-toxic anti-radiation means. The main criterion for the development of stochastic consequences of exposure is radiation-induced genome instability, which is a promoter of carcinogenesis. The use of radiomitigators, which are able to weaken the harmful effect of ionizing radiation on critical highly radiosensitive systems of the human body, is promising. Our research showed the radiomitigative effect of inosine in cultured human T-lymphocytes on the genetic level with the significant decrease in the frequency of gamma-induced chromosome aberrations. The results experimentally justified an expediency of use of radiomitigators in the conditions of an emergency situation to minimize the occurrence and development of stochastic effects in population.

辐射防护在减少辐射事件随机效应中的作用。
乌克兰紧急局势的真正威胁决定了必须考虑到以往辐射事故的经验,在这些事故中,很大一部分人口受到低剂量辐射的照射。在这种情况下,辐照的临床表现大多不存在,而随机(致癌)效应的危险仍然存在。因此,当前人群的辐射防护策略应以修正和选择有效、低毒的抗辐射手段为目标。暴露的随机后果发展的主要标准是辐射引起的基因组不稳定,这是致癌的一个启动子。辐射缓减剂的使用是有希望的,它能够削弱电离辐射对人体关键的高度辐射敏感系统的有害影响。我们的研究表明,肌苷在培养的人t淋巴细胞中具有遗传水平的放射抑制作用,显著降低了γ诱导的染色体畸变的频率。实验结果证明了在紧急情况下使用辐射缓释剂的权宜之计,以尽量减少人口中随机效应的发生和发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Experimental oncology
Experimental oncology Medicine-Oncology
CiteScore
1.40
自引率
0.00%
发文量
49
期刊介绍: The Experimental Oncology is an English-language journal that publishes review articles, original contributions, short communications, case reports and technical advances presenting new data in the field of experimental and fundamental oncology. Manuscripts should be written in English, contain original work, which has not been published or submitted for publication elsewhere. It also implies the transfer of the Copyright from the author to “Experimental Oncology”. No part of journal publications may be reproduced, stored in a retrieval system or transmitted in any form or by any means without the prior permission of the publisher.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信